Ist eine MRT zum Screening eines hepatozellulären Karzinoms sinnvoll?

Literatur

• 1 Farinati F, Gianni S. Surveillance for hepatocellular carcinoma in cirrhosis: is it cost- effective?.  Eur J Cancer Prev. 2001;  10 111-115
• 2 Sarasin F P, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis.  Am J Med. 1996;  101 422-434
• 3 Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.  Gut. 2001;  48 251-259
• 4 Solmi L, Primerano A M, Gandolfi L. Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases.  Am J Gastroenterol. 1996;  91 1189-1194
• 5 Unoura M, Kaneko S, Matsushita E, Shimoda A, Takeuchi M, Adachi H, Kawai H, Urabe T, Yanagi M, Matsui O. et al . High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease.  Hepatogastroenterology. 1993;  40 305-310
• 6 Schoniger-Hekele M, Muller C, Kutilek M, Oesterreicher C, Ferenci P, Gangl A. Hepatocellular carcinoma in Central Europe: prognostic features and survival.  Gut. 2001;  48 103-109
• 7 Rabe C, Pilz T, Klostermann C, Berna M, Schild H H, Sauerbruch T, Caselmann W H. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.  World J Gastroenterol. 2001;  7 208-215
• 8 Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Haussinger D. Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic.  Z Gastroenterol. 1997;  35 1059-1067
• 9 Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, Henry L, Berger F, Bizollon T, Gaudin J L, Ducerf C. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver.  J Comput Assist Tomogr. 2001;  25 327-336
• 10 Kubicka S, Rudolph K L, Hanke M, Tietze M K, Tillmann H L, Trautwein C, Manns M. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.  Liver. 2000;  20 312-318
• 11 Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.  Hepatology. 1994;  19 61-66
• 12 Caselmann W H, Blum H E, Fleig W E, Huppert P E, Ramadori G, Schirmacher P, Sauerbruch T. Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zur Diagnostik und Therapie des hepatozellulären Karzinoms.  Z Gastroenterol. 1999;  37 353-365
• 13 Krinsky G A, Lee V S, Theise N D, Weinreb J C, Rofsky N M, Diflo T, Teperman L W. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation.  Radiology. 2001;  219 445-454

Autoren